Pharmacokinetics and brain distribution in non human primate of R(-)[123I]DOI, A 5HT(2A/2C) serotonin agonist (Q44044340)

29 November 2017

title

Pharmacokinetics and brain distribution in non human primate of R(-)[123I]DOI, A 5HT(2A/2C) serotonin agonist (English)

1 reference

29 November 2017

0 references

Yolanda Zea-Ponce

1 reference

29 November 2017

Lawrence S Kegeles

1 reference

29 November 2017

Ningning Guo

1 reference

29 November 2017

Leonid Raskin

1 reference

29 November 2017

Venkatesalu Bakthavachalam

1 reference

29 November 2017

Marc Laruelle

1 reference

29 November 2017

publication date

1 July 2002

1 reference

Nuclear Medicine and Biology

29 November 2017

published in

1 reference

29 November 2017

1 reference

29 November 2017

1 reference

29 November 2017

page(s)

575-583

1 reference

A review of central 5-HT receptors and their function

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900306-2

7 January 2021

Effect of the selective 5-HT receptor agonists 8-OHDPAT and DOI on behavior and brain biogenic amines of rats

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900306-2

7 January 2021

[125I]-1-(2,5-dimethoxy-4-iodophenyl)-2-amino-propane: an iodinated radioligand that specifically labels the agonist high-affinity state of 5-HT2 serotonin receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900306-2

7 January 2021

Discriminative stimulus properties of the serotonergic agent 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI).

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900306-2

7 January 2021

Behavioral and serotonin receptor properties of 4-substituted derivatives of the hallucinogen 1-(2,5-dimethoxyphenyl)-2-aminopropane

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900306-2

7 January 2021

DOI, a 5-HT2A/2C receptor agonist, potentiates amphetamine-induced dopamine release in rat striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900306-2

7 January 2021

[125I]-2-(2,5-dimethoxy-4-iodophenyl)aminoethane ([125I]-2C-I) as a label for the 5-HT2 receptor in rat frontal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900306-2

7 January 2021

Binding to the serotonin 5-HT2 receptor by the enantiomers of 125I-DOI.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900306-2

7 January 2021

Potentiation of DOI-induced forward locomotion in rats by (?)-pindolol pretreatment

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900306-2

7 January 2021

Fluoxetine gradually increases [125I]DOI-labelled 5-HT2A/2C receptors in the hypothalamus without changing the levels of Gq- and G11-proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900306-2

7 January 2021

Mapping of 5-HT2A receptors and their mRNA in monkey brain: [3H]MDL100,907 autoradiography and in situ hybridization studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900306-2

7 January 2021

Common receptors for hallucinogens in rat brain: a comparative autoradiographic study using [125I]LSD and [125I]DOI, a new psychotomimetic radioligand

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900306-2

7 January 2021

Autoradiographic localization of binding sites for 125I-DOI, a new psychotomimetic radioligand, in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900306-2

7 January 2021

Serotonin 5-HT2A receptors: molecular biology and mechanisms of regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900306-2

7 January 2021

In vivo human pharmacodynamics of the psychodysleptic 4-BR-2,5-dimethoxyphenylisopropylamine labelled with 'BRor 'BR.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900306-2

7 January 2021

Blockade of the discriminative stimulus effects of DOI by MDL 100,907 and the 'atypical' antipsychotics, clozapine and risperidone

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900306-2

7 January 2021

Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900306-2

7 January 2021

Selectivity of action of typical and atypical anti-psychotic drugs as antagonists of the behavioral effects of 1-[2,5-dimethoxy-4-iodophenyl]-2-aminopropane (DOI).

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900306-2

7 January 2021

Protein precipitation: an expedient procedure for the routine analysis of the plasma metabolites of [123I]IBZM

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900306-2

7 January 2021

The in vivo effects of olanzapine and other antipsychotic agents on receptor occupancy and antagonism of dopamine D1, D2, D3, 5HT2A and muscarinic receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900306-2

7 January 2021

10.1016/S0969-8051(02)00306-2

Identifiers

DOI

1 reference

release_w4kuspkci5hwrfgi3wmaixgqbq

29 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/w4kuspkci5hwrfgi3wmaixgqbq

24 November 2022

mapped directly with Wikidata item

1 reference